Valsartan can inhibit oxidative stress, thereby inhibiting the MEK/ERK signaling pathway and promoting Nrf1 expression, effectively relieving rat kidney tissue morphology, improving protein expression in kidney tissue of DN rats, and reducing renal tissue fibrosis and inflammation. Here, MAP2K7 is linked to liver dysplastic nodule.